218 related articles for article (PubMed ID: 17592115)
1. Pathological role of osteoclast costimulation in arthritis-induced bone loss.
Ochi S; Shinohara M; Sato K; Gober HJ; Koga T; Kodama T; Takai T; Miyasaka N; Takayanagi H
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11394-9. PubMed ID: 17592115
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.
Mori Y; Tsuji S; Inui M; Sakamoto Y; Endo S; Ito Y; Fujimura S; Koga T; Nakamura A; Takayanagi H; Itoi E; Takai T
J Immunol; 2008 Oct; 181(7):4742-51. PubMed ID: 18802077
[TBL] [Abstract][Full Text] [Related]
3. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
[TBL] [Abstract][Full Text] [Related]
4. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells.
Blüml S; Friedrich M; Lohmeyer T; Sahin E; Saferding V; Brunner J; Puchner A; Mandl P; Niederreiter B; Smolen JS; Schabbauer G; Redlich K
Ann Rheum Dis; 2015 Jan; 74(1):227-33. PubMed ID: 24078675
[TBL] [Abstract][Full Text] [Related]
5. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model.
Mukai T; Gallant R; Ishida S; Yoshitaka T; Kittaka M; Nishida K; Fox DA; Morita Y; Ueki Y
PLoS One; 2014; 9(8):e105518. PubMed ID: 25144740
[TBL] [Abstract][Full Text] [Related]
6. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass.
Adamopoulos IE; Tessmer M; Chao CC; Adda S; Gorman D; Petro M; Chou CC; Pierce RH; Yao W; Lane NE; Laface D; Bowman EP
J Immunol; 2011 Jul; 187(2):951-9. PubMed ID: 21670317
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells protect from local and systemic bone destruction in arthritis.
Zaiss MM; Frey B; Hess A; Zwerina J; Luther J; Nimmerjahn F; Engelke K; Kollias G; Hünig T; Schett G; David JP
J Immunol; 2010 Jun; 184(12):7238-46. PubMed ID: 20483756
[TBL] [Abstract][Full Text] [Related]
8. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
9. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts.
Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N
Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426
[TBL] [Abstract][Full Text] [Related]
11. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
Romas E; Sims NA; Hards DK; Lindsay M; Quinn JW; Ryan PF; Dunstan CR; Martin TJ; Gillespie MT
Am J Pathol; 2002 Oct; 161(4):1419-27. PubMed ID: 12368214
[TBL] [Abstract][Full Text] [Related]
13. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
14. NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis.
Aya K; Alhawagri M; Hagen-Stapleton A; Kitaura H; Kanagawa O; Novack DV
J Clin Invest; 2005 Jul; 115(7):1848-54. PubMed ID: 15937549
[TBL] [Abstract][Full Text] [Related]
15. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
16. Low-Dose Radiotherapy Ameliorates Advanced Arthritis in hTNF-α tg Mice by Particularly Positively Impacting on Bone Metabolism.
Deloch L; Derer A; Hueber AJ; Herrmann M; Schett GA; Wölfelschneider J; Hahn J; Rühle PF; Stillkrieg W; Fuchs J; Fietkau R; Frey B; Gaipl US
Front Immunol; 2018; 9():1834. PubMed ID: 30279685
[TBL] [Abstract][Full Text] [Related]
17. Suppressors of cytokine signaling-1 and -3 regulate osteoclastogenesis in the presence of inflammatory cytokines.
Ohishi M; Matsumura Y; Aki D; Mashima R; Taniguchi K; Kobayashi T; Kukita T; Iwamoto Y; Yoshimura A
J Immunol; 2005 Mar; 174(5):3024-31. PubMed ID: 15728516
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice.
Seeling M; Hillenhoff U; David JP; Schett G; Tuckermann J; Lux A; Nimmerjahn F
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10729-34. PubMed ID: 23754379
[TBL] [Abstract][Full Text] [Related]
19. Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.
Li CH; Ma ZZ; Jian LL; Wang XY; Sun L; Liu XY; Yao ZQ; Zhao JX
Int Immunopharmacol; 2021 Jan; 90():107219. PubMed ID: 33307512
[TBL] [Abstract][Full Text] [Related]
20. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
